During our investigation, greater than 50% of breast cancer specimens overexpressed PKCζ, and PKCζ that were related to pathological and prognostic characteristics, including clinical stage, lymph node metastasis status, tumor size, HER2 status and survival rate. The gene discussed is ERBB2; the disease is breast cancer.